NRXP icon

NRX Pharmaceuticals

19 hedge funds and large institutions have $41.4M invested in NRX Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
HIM
1
HGC Investment Management
Ontario, Canada
$4.72M 476,257 +51,000 +12%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$4.64M 468,300 +37,500 +9%
OAM
3
Oxford Asset Management
United Kingdom
$4.09M 412,635 +127,635 +45%
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$3.49M 352,385 +352,385 New
BFM
5
Boothbay Fund Management
New York
$2.97M 300,000 -239,526 -44%
KIM
6
Karpus Investment Management
New York
$2.51M 252,917 +1,425 +0.6%
PC
7
Periscope Capital
Ontario, Canada
$2.5M 252,000 +100,800 +67%
BI
8
Bulldog Investors
New Jersey
$2.44M 245,667 -5,838 -2%
WCMNY
9
Westchester Capital Management (New York)
New York
$2.43M 244,758
WRBC
10
W.R. Berkley Corp
Connecticut
$2.01M 202,748
AA
11
AQR Arbitrage
Connecticut
$1.98M 200,000
GCL
12
Glazer Capital LLC
New York
$1.91M 192,213 +325 +0.2%
RCM
13
Rivernorth Capital Management
Florida
$1.79M 180,082 +180,082 New
YCM
14
Yakira Capital Management
Connecticut
$1.64M 165,000
KPF
15
K2 Principal Fund
Ontario, Canada
$1.45M 146,391
BCM
16
Basso Capital Management
Connecticut
$531K 53,600
HCMT
17
Highland Capital Management (Texas)
Texas
$271K 27,367 +27,367 New
BCM
18
Bluefin Capital Management
New York
$36K 101,600
UBS Group
19
UBS Group
Switzerland
$13K 1,300
WAM
20
Weiss Asset Management
Massachusetts
-381,400 Closed
DAM
21
Deltec Asset Management
New York
-75,000 Closed